glp-1 smoking New research: receptor agonists may support nicotine cessation GLP-1 Therapy: A Promising Approach

Non-human-primate findings require confirmation through properly designed human studies before a treatment claim can be considered

Taking the Next Step in Your Health Journey If you are struggling with cognitive dysfunction, peripheral neuropathy, or the debilitating fatigue associated with Long COVID and ME/CFS, targeted neurological support may be a vital piece of your recovery puzzle

A study of patients with non-alcoholic fatty liver disease (NAFLD) revealed that giving 300 mg of glutathione daily for four months resulted in significant reductions in elevated ALT (an enzyme associated with liver damage), triglycerides, and ferritin

Both peptides are generally considered well-tolerated in preclinical studies, but mild injection-site reactions, nausea, dizziness, or rare allergic responses have been reported